Close

WAYLIVRA▼® (volanesorsen), the First and Only Therapy for FCS, an Ultra-Rare and Life-Threatening Condition, to Be Available on the NHS in England

Go back to WAYLIVRA▼® (volanesorsen), the First and Only Therapy for FCS, an Ultra-Rare and Life-Threatening Condition, to Be Available on the NHS in England
(NASDAQ: AKCA) Delayed: 18.17 --0 (-0%)
Previous Close $18.17    52 Week High
Open $22.77    52 Week Low
Day High $18.17    P/E N/A 
Day Low $18.17    EPS
Volume 2,023       

(NASDAQ: IONS) Delayed: 40.68 -0.13 (0.32%)
Previous Close $40.81    52 Week High $62.68 
Open $40.88    52 Week Low $19.59 
Day High $41.16    P/E N/A 
Day Low $40.39    EPS $0.00 
Volume 846,040